Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based Chemotherapy.
Walter RF, Vollbrecht C, Werner R, Mairinger T, Schmeller J, Flom E, Wohlschlaeger J, Barbetakis N, Paliouras D, Chatzinikolaou F, Adamidis V, Tsakiridis K, Zarogoulidis P, Trakada G, Christoph DC, Schmid KW, Mairinger FD. Walter RF, et al. Among authors: wohlschlaeger j. J Cancer. 2016 Sep 13;7(13):1915-1925. doi: 10.7150/jca.16390. eCollection 2016. J Cancer. 2016. PMID: 27698933 Free PMC article.
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.
Schmitz KJ, Grabellus F, Callies R, Otterbach F, Wohlschlaeger J, Levkau B, Kimmig R, Schmid KW, Baba HA. Schmitz KJ, et al. Among authors: wohlschlaeger j. Breast Cancer Res. 2005;7(2):R194-203. doi: 10.1186/bcr977. Epub 2005 Jan 7. Breast Cancer Res. 2005. PMID: 15743500 Free PMC article.
Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways.
Schmitz KJ, Callies R, Wohlschlaeger J, Kimmig R, Otterbach F, Bohr J, Lee HS, Takeda A, Schmid KW, Baba HA. Schmitz KJ, et al. Among authors: wohlschlaeger j. J Clin Pathol. 2006 Jul;59(7):685-91. doi: 10.1136/jcp.2005.030650. Epub 2006 Feb 23. J Clin Pathol. 2006. PMID: 16497869 Free PMC article.
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.
Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K, Reis H, Cicinnati VR, Schmid KW, Baba HA. Schmitz KJ, et al. Among authors: wohlschlaeger j. J Hepatol. 2008 Jan;48(1):83-90. doi: 10.1016/j.jhep.2007.08.018. Epub 2007 Oct 29. J Hepatol. 2008. PMID: 17998146
114 results